Using CollaboRATE, a brief patient-reported measure of shared decision making: Results from three clinical settings in the United States. by Forcino, Rachel C et al.
UC San Diego
UC San Diego Previously Published Works
Title
Using CollaboRATE, a brief patient-reported measure of shared decision making: Results 
from three clinical settings in the United States.
Permalink
https://escholarship.org/uc/item/3bw4s79b
Journal
Health expectations : an international journal of public participation in health care and 
health policy, 21(1)
ISSN
1369-7625
Authors
Forcino, Rachel C
Barr, Paul J
O'Malley, A James
et al.
Publication Date
2018-02-01
DOI
10.1111/hex.12588
 
Peer reviewed
eScholarship.org Powered by the California Digital Library
University of California
82  |    Health Expectations. 2018;21:82–89.wileyonlinelibrary.com/journal/hex
Accepted: 16 May 2017
DOI: 10.1111/hex.12588
O R I G I N A L  R E S E A R C H  P A P E R
Using CollaboRATE, a brief patient- reported measure of shared 
decision making: Results from three clinical settings in the 
United States
Rachel C. Forcino MSc, Research Project Coordinator1  | Paul J. Barr PhD, Assistant 
Professor1 | A. James O’Malley PhD, Professor of Biostatistics1 | Roger Arend BS, Patient 
Representative2 | Molly G. Castaldo JD, MPH, Assistant Director of Alumni Engagement3 |  
Elissa M. Ozanne PhD, Associate Professor4 | Sanja Percac-Lima MD, PhD, Assistant Professor, 
Physician5,6 | Cheryl D. Stults PhD, Research Sociologist7 | Ming Tai-Seale PhD, MPH, Associate 
Director7 | Rachel Thompson PhD, Assistant Professor1 | Glyn Elwyn MD, PhD, Professor1
This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, 
provided the original work is properly cited.
© 2017 The Authors Health Expectations Published by John Wiley & Sons Ltd
1The Dartmouth Institute for Health Policy & 
Clinical Practice, Lebanon, NH, USA
2Dartmouth-Hitchcock Patient and Family 
Advisory Council, Lebanon, NH, USA
3Dartmouth Master of Health Care Delivery 
Science Program, Hanover, NH, USA
4Department of Population Health 
Sciences, University of Utah, Salt Lake City, 
UT, USA
5Harvard Medical School, Boston, MA, USA
6Massachusetts General Hospital Chelsea 
HealthCare Center, Chelsea, MA, USA
7Palo Alto Medical Foundation Research 
Institute, Palo Alto, CA, USA
Correspondence
Glyn Elwyn, The Dartmouth Institute for 
Health Policy & Clinical Practice, Lebanon, 
NH, USA.
Email: glynelwyn@gmail.com
Funding information
This study was funded by the Gordon and 
Betty Moore Foundation (grant #3929)
Abstract
Introduction: CollaboRATE is a brief patient survey focused on shared decision mak-
ing. This paper aims to (i) provide insight on facilitators and challenges to implementing 
a real- time patient survey and (ii) evaluate CollaboRATE scores and response rates 
across multiple clinical settings with varied patient populations.
Method: All adult patients at three United States primary care practices were eligible 
to complete CollaboRATE post- visit. To inform key learnings, we aggregated all men-
tions of unanticipated decisions, problems and administration errors from field notes 
and email communications. Mixed- effects logistic regression evaluated the impact of 
site, clinician, patient age and patient gender on the CollaboRATE score.
Results: While CollaboRATE score increased only slightly with increasing patient age 
(OR 1.018, 95% CI 1.014- 1.021), female patient gender was associated with signifi-
cantly higher CollaboRATE scores (OR 1.224, 95% CI 1.073- 1.397). Clinician also pre-
dicts CollaboRATE score (random effect variance 0.146). Site- specific factors such as 
clinical workflow and checkout procedures play a key role in successful in- clinic imple-
mentation and are significantly related to CollaboRATE scores, with Site 3 scoring 
significantly higher than Site 1 (OR 1.759, 95% CI 1.216 to 2.545) or Site 2 (z=−2.71, 
95% CI −1.114 to −0.178).
Discussion: This study demonstrates that CollaboRATE can be used in diverse primary 
care settings. A clinic’s workflow plays a crucial role in implementation. Patient experi-
ence measurement risks becoming a burden to both patients and administrators. 
Episodic use of short measurement tools could reduce this burden.
K E Y W O R D S
patient experience measure, shared decision-making, survey
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1  | INTRODUCTION
An emphasis in United States (US) health- care policy on improving pa-
tient experiences of care has led to increased focus on structural and 
process measures of health care, including patient satisfaction with 
health- care facilities, personnel and service delivery.1-4 Recently, inter-
est has grown in shared decision making, a process where patients are 
supported to participate in health- care decisions. Given this interest, 
CollaboRATE was developed as a process measure of shared decision 
making (SDM) between patients and clinicians.5,6
Existing patient experience measurement typically involves 
lengthy surveys that ask patients to recall encounters occurring up to 
6 months in the past.7 In contrast, CollaboRATE is brief and focuses on 
a core construct, namely the perception of being informed and then 
involved in decision- making steps. This focus reduces survey burden 
and enables the use of efficient and inexpensive survey administration 
methods which minimize the delay between a patient experiencing a 
health- care interaction and responding to an evaluation survey (eg,. 
using text messages or automated telephone calls). This real- time sur-
vey administration allows patients to more easily recall their satisfac-
tion with care, and Stull et al.8 find recall of satisfaction to be optimal 
within days of a clinic visit.
Few studies measure outpatient care experiences close to the 
time of visit and those that do are often conducted in the context of 
a specific disease.9,10 One exception is found in Tai- Seale’s11 cluster 
randomized pilot trial of recently developed SDM interventions, where 
SDM was assessed immediately post- visit. Further, adding a quality 
improvement perspective to data collection requirements poses ad-
ditional feasibility challenges. Instead of deploying dedicated research 
staff to ensure survey completion, the measurement of patient experi-
ence in usual practice settings may require clinic staff to take on new 
tasks in addition to their existing workloads. Despite widespread pa-
tient survey administration as part of clinical operations, the available 
literature provides little insight on how to best administer real- time 
patient surveys. Emerging research from Carter et al.12 begins to ad-
dress this issue in the United Kingdom’s National Health Service; the 
current paper expands on this effort by incorporating insights from 
diverse US practices.
In light of the emphasis placed on process measures of patient ex-
perience and the paucity of reports addressing feasibility and results of 
routine, real- time, patient- reported measurement of shared decision 
making across multiple sites, we aim to (i) provide insight on facilita-
tors and challenges to implementing a real- time patient survey and 
(ii) evaluate CollaboRATE scores and response rates across multiple 
primary care clinical settings with varied patient populations.
2  | METHOD
As part of a quality improvement initiative, we collected CollaboRATE 
post- visit survey data at three geographically and demographically var-
ied primary care practices within the United States: Lebanon in New 
Hampshire, Los Gatos in California and Chelsea in Massachusetts.
2.1 | Data
2.1.1 | CollaboRATE
The CollaboRATE questions are as follows: (i) How much effort was 
made to help you understand your health issues? (ii) How much effort 
was made to listen to what matters most to you about your health is-
sues? (iii) How much effort was made to include what matters most to 
you in choosing what to do next? CollaboRATE survey data included 
responses to the three CollaboRATE questions, each on a 0- 9 scale, 
along with each respondent’s age, gender and clinician. CollaboRATE 
has previously been validated in a simulation sample5 and included 
significant end- user input in its development.6
2.1.2 | Field notes
Field notes regarding implementation challenges and solutions were 
kept on an ad hoc basis by study staff at all sites throughout the pro-
ject as an integral part of project management processes. Investigators 
and research staff from all sites contributed observations through 
email messages and regular project meetings; meetings were held 
weekly at Site 1 and quarterly between Sites 1 and 2 and Sites 1 and 3. 
All contributors were familiar with the study protocol and participated 
in the design of survey implementation at their respective sites. Field 
notes were collected, organized and held by the project coordinator 
based at the Lebanon, NH site. All instances of unanticipated deci-
sions, problems and errors were documented.
2.2 | Settings, participants and data collection 
processes
2.2.1 | Overview
Setting
Three geographically diverse US primary care practices were included 
in this study: Lebanon, NH (Site 1); Los Gatos, CA (Site 2); and Chelsea, 
MA (Site 3). Detailed information on each site is included below.
Participants
All adult patients ages 18 and older visiting the participating primary 
care teams were eligible to participate.
Data collection process
All sites allowed clinicians to describe the survey to patients, al-
though this behaviour was eventually encouraged as a participation- 
enhancing measure only at the Los Gatos site. No clinicians at any site 
personally delivered the survey to their patients.
2.2.2 | Site 1: Lebanon, New Hampshire
Setting details
This setting included three primary care teams based in a rural aca-
demic medical centre in New Hampshire with approximately 16 000 
84  |     FORCINO et al.
patients. Clinicians included physicians, physicians’ assistants, nurses, 
nurse practitioners and pharmacists. The patient population is more 
than 95% white and non- Hispanic, and 99% of patients speak English 
as a primary language.
Participant details
Parents and guardians of patients under 18 were also eligible to com-
plete CollaboRATE on behalf of their children at this site.
Data collection process
This site aimed to administer CollaboRATE for 15 consecutive 
months beginning in April 2014 in order to embed the survey in rou-
tine practice. Administrative staff were asked to notify patients at 
check- in of the on going research study. The study was reviewed by 
the Dartmouth Committee for the Protection of Human Subjects and 
written participant consent requirements were waived for all modes 
of survey administration. Five survey administration modes were im-
plemented consecutively: (i) paper survey in- clinic from April through 
July 2014; (ii) patients were alerted to a survey hosted on the online 
patient portal (MyChart) of the Epic electronic medical record system 
from July through November 2014; (iii) automated interactive voice 
response (IVR) telephone calls were made to patients’ cellular tele-
phones from December 2014 through March 2015; (iv) short mes-
saging service (SMS) text messages were sent to patients’ cellular 
telephones from April through July 2015; (v) a tablet computer survey 
was presented to patients in- clinic, with an option for patients to mail 
back a paper- based survey if they declined to complete the tablet sur-
vey (July through October 2015); see Appendix 1 for detail. The study 
population at the Lebanon, NH site included all patients for whom 
institutional constraints did not explicitly bar survey delivery, that is 
all patients during paper delivery mode, all patients with online patient 
portal accounts in the MyChart mode, and patients with cellular tel-
ephone numbers on record in the IVR and SMS modes.
2.2.3 | Site 2: Los Gatos, California
Setting details
This primary care clinic in suburban Los Gatos, CA is one of many 
community- based clinics of the Palo Alto Medical Foundation, a 
large, not- for- profit health- care delivery system in the San Francisco 
Bay Area, and has a patient panel of approximately 13 000. The pa-
tient population is predominantly Caucasian (44%) and Asian (34%). 
Approximately 90% of patients speak English as a primary language, 
with 46 other language groups also represented.
Data collection process
This site aimed to collect 300 completed CollaboRATE surveys dur-
ing the February 2015- March 2015 study period. The study was re-
viewed by the Sutter Health Institutional Review Board and written 
participant consent requirements were waived. An initial week- long 
pilot period involved only the reception staff informing patients about 
the CollaboRATE survey as they arrived for their visit. After their 
visit, a receptionist invited all eligible patients to complete a paper 
survey containing CollaboRATE. The pilot period yielded very low re-
sponse rates (2%). Recruitment in the subsequent data collection pe-
riod included asking physicians to encourage participation, additional 
reminder signage, and medical assistants providing patients with 
surveys before they left the exam room. A locked collection box was 
placed at the clinic exit with a sign reminding patients to deposit the 
completed survey in the box. Thus, the physical clinic layout did not 
present a barrier to survey completion at this site. The study popula-
tion at the Los Gatos, CA site included all patients visiting the partici-
pating clinics.
2.2.4 | Site 3: Chelsea, Massachusetts
Setting details
This urban adult medicine practice is based in a Massachusetts 
General Hospital affiliated community health centre in Chelsea, MA 
and has a patient panel of approximately 14 000 patients. Fifty per-
cent of patients are Latino, 31% white, 9% black and 4% other. Fifty- 
one percent of patients at this site speak English as their primary 
language, while 38% speak only Spanish and 11% speak one of 14 
other languages.
Data collection process
This site aimed to administer the CollaboRATE survey for the month 
of May 2015. The study was reviewed by the Partners Institutional 
Review Board and written participant consent requirements were 
waived. Medical assistants (MAs) assigned to meet with patients 
following their visits delivered the survey to patients. Survey forms 
were available in both English and Spanish.13 Completed surveys were 
placed in a secure box at the clinic’s exit. To encourage uptake, the 
Chelsea clinic provided each participating MA with a $100 one- time 
payment. The study population at the Chelsea, MA site included all 
patients visiting the participating clinic.
2.3 | Analysis
Returned surveys missing one or more CollaboRATE responses were 
considered incomplete and excluded from analysis. Descriptive sta-
tistics compared response rates and CollaboRATE scores across sites. 
Because patient reported experience measures often show ceiling 
effects, we decided a priori to conduct a top score analysis which 
has been shown to enhance variation in scores5,.14 Therefore, the 
CollaboRATE score represents the proportion of patients (minimum 
sample size of 25) responding with the highest possible score on all 
three questions. The unit of analysis was patients.
As data were clustered by site and clinician, we used mixed- 
effects logistic regression analysis to evaluate the impact of site and 
clinician on the dichotomous CollaboRATE score outcome variable 
(ie, top score for all three questions or not top score) while con-
trolling for the survey administration modality and patient- level de-
mographic characteristics of age and gender. Clinician was included 
as a random effect within the mixed- effects regression model (with 
resulting clinician variance estimate) to account for clustering of 
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responses and to allow our results to be generalizable to the popu-
lation of all clinicians who would plausibly work at one of the three 
sites, not just those in our study, as the random effect specification 
accounts for the possibility that studying a different group of clini-
cians may have yielded different results. Site was included as a fixed 
effect because the small number of sites (3) provided insufficient 
numbers of sites to reliably estimate a site- level variance component 
under a random- effects specification. Thus, we control for the sites 
in the study rather than generalizing results to a larger population 
of sites. While the logistic regression model allows us to compare 
Los Gatos and Chelsea sites to the Lebanon reference group, the 
logistic regression model does not allow us to test the difference 
between scores at the Los Gatos and Chelsea sites. Therefore, as a 
post- estimation hypothesis test, we calculated a z- score to compare 
CollaboRATE scores at the Los Gatos and Chelsea sites. An inverse 
logit transformation involving the clinician random effect variance 
parameter allowed the magnitude of the clinician effect to be com-
pared to that of the model’s regression parameters on the probability 
scale.15 To assess effect modification by site, we reran the original 
mixed- effects logistic regression model described above, this time 
including two interaction terms accounting for associations between 
site and patient age or gender, respectively. Survey data was anal-
ysed with Stata 13 software.16
To inform the key learnings and descriptions of site- level char-
acteristics, we aggregated all mentions of unanticipated decisions, 
problems, and administration errors from field notes and email 
communications.
3  | RESULTS
3.1 | Response rates by site
Response rates varied across sites, with Site 3 (Chelsea, MA) achiev-
ing the highest response rate of 73% compared to 25% overall at 
Site 1 (Lebanon, NH) and 30% at Site 2 (Los Gatos, CA). Site 1 saw 
variation in response rates across the various administration modes, 
described in detail elsewhere.17 Of all surveys returned, missing 
CollaboRATE data were minimal: <0.5% at Site 1, <1% at Site 2, and 
<0.1% at Site 3.
3.2 | Factors influencing CollaboRATE scores
Table 1 demonstrates variation in CollaboRATE score by site, with 
Site 1 (Lebanon, NH) achieving an overall score of 68% and response 
rate of 25%, Site 2 (Los Gatos, CA) achieving an overall score of 76% 
and response rate of 30%, and Site 3 (Chelsea, MA) achieving an over-
all score of 86% and response rate of 73%.
While Los Gatos patients were similar to Lebanon patients in their 
propensity to give a top score on all three CollaboRATE items, Chelsea 
patients were more likely than those at the Lebanon (OR 1.759, 95% 
CI 1.216 to 2.545) and Los Gatos (z=−2.71, 95% CI −1.114 to −0.178, 
P=.007) sites to give all top scores. The clinician random effect vari-
ance of 0.146 implies that the distribution of CollaboRATE scores var-
ied substantially between clinicians; for this study the random effect 
standard deviation of 0.382 translates to a difference of 0.5364 on the 
probability scale. Thus, a clinician whose scores fall one standard devi-
ation above the mean clinician will have a 53.64% greater probability 
of obtaining a perfect CollaboRATE score from a randomly selected 
patient.
Patient demographics also play a role. Table 2 shows that while 
CollaboRATE score increased only slightly with increasing patient 
age (OR 1.018, 95% CI 1.014 to 1.021), female patient gender was 
TABLE  1 Site- level CollaboRATE scores and response rates
Overall 
score(%)
Clinician score 
range(%)
Response 
rate(%) Sample size Population size
Participating 
clinicians (n)
Site 1: Lebanon, NH 68 42 - 93 25 4421 17568 34
Mode 1 81 72 - 93 12 541 4692 –
Mode 2 71 59 - 83 34 1019 3015 –
Mode 3 61 42 - 75 25 893 3589 –
Mode 4 65 46 - 82 23 757 3329 –
Mode 5 66 53 - 83 41 1211 2943 –
Site 2: Los Gatos, CA 76 66 - 91 30 323 1094 12
Site 3: Chelsea, MA 86 76 - 99 73 1230 1687 18
TABLE  2 Characteristics contributing to variation in CollaboRATE 
scores: mixed- effects logistic regression
Random effects
Variance 
estimate
95% Confidence 
interval
Clinician 0.146 0.076 0.282
Fixed effectsa Odds ratio
95% Confidence 
interval
Site 1: Lebanon, NH  
(reference)
1.000 – –
Site 2: Los Gatos, CA 0.922 0.570 1.492
Site 3: Chelsea, MA 1.759 1.216 2.545
Patient age 1.018 1.014 1.021
Patient gender: Female 1.224 1.073 1.397
Constant 1.452 1.036 2.034
aOdds ratios for survey administration modes are available upon request.
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associated with significantly higher CollaboRATE scores across 
the three sites (OR 1.224, 95% CI 1.073 to 1.397). Our effect 
modification analysis including interaction terms for associations 
between site and gender and age variables yielded no significant 
interactions, suggesting the effect of patient age and gender on 
CollaboRATE scores is not substantially moderated by site (see 
Appendix 2).
3.3 | Key learnings and site- level characteristics
The following key learnings and other site- level characteristics may 
contribute to the observed variation in CollaboRATE response rates 
and CollaboRATE scores by site.
3.3.1 | Site 1: Lebanon, New Hampshire
The relatively novel patient survey administration procedures used in 
patient portal, IVR, and SMS modes presented logistical challenges. 
We relied on the medical centre’s information systems department 
for programming key aspects of survey administration. We were not 
able to negotiate priority status for our programming needs, given 
other competing deadlines in the organizational work schedule, and 
this led to delays and errors. For example, limitations of existing soft-
ware meant survey format was not exactly as we had stipulated and 
we were unable to ensure that the invitation to complete the survey 
on the patient portal was sent from a neutral source and not from their 
own clinician. We concluded that unless collecting patient experience 
data was an organizational priority, other organizations’ information 
systems may be reluctant to facilitate in- house digital methods of pa-
tient survey administration. Capacity for engaging external contrac-
tors or an on- staff programmer might have eliminated these delays, 
although the need for integration into existing administrative systems 
would still exist.
In the paper survey administration mode, patients who did not 
need to schedule follow- up appointments often did not make the 
effort to collect the CollaboRATE survey from the assigned staff 
person, despite this process being intended to occur for each pa-
tient. The location of the staff assigned to distribute surveys was 
not convenient, as their offices were not located near the clinic 
exit and access by patients often required exiting the consultation 
room and walking away from the clinic exit. As such, many patients 
may not have received or completed CollaboRATE due to the clinic 
layout.
Our attempts to use text messaging (SMS) on cellular telephones 
also revealed logistical challenges due to significant variation in sub-
scriber plans and very limited reception in some rural areas. In the 
United States, some cellular telephone subscribers pay a fee (<$0.50 
USD) for each text message sent or received. Some cellular service 
providers offer to deliver an organization’s outgoing messages to their 
customers free of charge for an annual $25 000 USD up- front fee, 
although that cost was prohibitive in this project. Despite the cost to 
patients, we used the SMS approach to assess text message patient 
survey administration in this study.
3.3.2 | Site 2: Los Gatos, California
At the Los Gatos site, the clinic’s physicians and operational leaders 
strongly supported the project. When the initial attempt to collect re-
sponses by asking receptionists to alert patients to the survey led to 
only 26 surveys completed over a two- week pilot period, we were 
able to consult with the two clinic leaders and change the survey ad-
ministration workflow. The new workflow ensured that both clinicians 
and reception staff were requesting survey completion, supported by 
the medical assistants giving surveys to patients as they finished their 
clinic visits. Using the modified recruitment methods, 323 surveys 
were completed during a two- week data collection period.
3.3.3 | Site 3: Chelsea, Massachusetts
We observed significant staff commitment to the data collection pro-
cess at this site. The clinic workflow and layout facilitated data collec-
tion; patients were required to make contact with administrative staff 
as they left the clinic, which provided an opportunity for staff to con-
firm receipt of the survey. We also believe that the additional financial 
incentive to MAs contributed to the 73% response rate achieved in 
this site.
4  | DISCUSSION
4.1 | Principal findings
Variation was found across the three sites with regard to both re-
sponse rates and CollaboRATE scores. Site- level factors were as-
sociated with scores at Site 3 (Chelsea) where response rates were 
highest, but these factors were not as influential as the clinician 
seen and the patient’s gender in accounting for observed variation in 
CollaboRATE scores. These generic site- level and clinician- level vari-
ables would include, as a component, the site or clinician’s actual level 
of performance. The range of scores at the clinician level indicates 
that the measure discriminates between high and low performing cli-
nicians. Additionally, associations between CollaboRATE scores and 
patient age and gender, respectively, show that older patients are 
only slightly more likely to give higher CollaboRATE scores than their 
younger peers, while women are much more likely than men to do so.
Our qualitative assessment found that site- level factors such as 
patient flows, physical clinic layout, and staff enthusiasm towards the 
project led to different response rates. Efforts to collect patient ex-
perience data close to clinical encounters need to negotiate two key 
challenges. First, scores are observed to have a wider range when 
CollaboRATE is completed outside the clinic environment. This may 
be due to social desirability bias where patients perceive in- clinic sur-
vey completion to be less private than completion elsewhere. Recency 
of the visit may also play a role in score differences observed when 
CollaboRATE is completed inside the clinic immediately after an ap-
pointment versus outside the clinic a short time (less than 24 hours) 
later. Second, efficient interfaces are needed between modern meth-
ods of collecting data using online and mobile technologies and the 
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administrative systems of health- care organizations. Existing systems 
are not currently designed to allow efficient communication with 
groups of patients. Adopting methods to assess, analyse and use pa-
tient experience data as inputs into quality improvement at the cli-
nician and clinic level will always be difficult unless real- time survey 
administration solutions requiring fewer in- clinic human resources are 
developed.
4.2 | Strengths and limitations
The participating sites represent a diverse group of rural, urban, and 
suburban primary care clinics in which CollaboRATE was successfully 
administered immediately following primary care clinic visits using 
multiple survey distribution modalities. Few studies have considered 
the challenges of collecting real- time patient experience data in such 
depth. Our data collection processes sought responses from all adult 
patients in real- world primary care practice, potentially avoiding selec-
tion bias that may result from collecting survey responses only from 
those patients who formally document written consent to participate 
in a research study; however, our lack of demographic data on non- 
respondents precludes definitive conclusions about selection bias. 
Additionally, the short length of the survey reduces the time burden 
placed on patients as a result of routine data collection.
Our lack of detailed patient demographic data may inflate esti-
mates of site and clinician impact on CollaboRATE scores.18-21 The vari-
ation in CollaboRATE score we observed between sites may therefore 
be due in part to the socio- demographic diversity of the respondent 
populations between sites or to selection bias due to differences in re-
sponse rates between sites, rather than to other potential site- specific 
sources of variation such as clinic layout and workflow. Additionally, 
we lack the ability to link survey responses to individual patients and 
therefore cannot model survey response through regression analysis. 
Demographic and performance data on clinicians, if it were available, 
may also help explain the existing relationship between clinician iden-
tity and CollaboRATE scores. Finally, we lack data on those patients 
at Los Gatos who were unable to participate because the survey was 
not available in their preferred language, although field notes did not 
include record of patients unable to complete the survey due to lan-
guage restrictions.
4.3 | Context within existing literature
This work contributes to a nascent area of inquiry surrounding real- 
time measurement of patient experience, particularly related to shared 
decision making. Tai- Seale’s11 overall CollaboRATE score of 72% is 
similar to the scores found in the current study, although that work 
focuses more on assessment of shared decision- making interventions 
than on our current question concerning feasibility of real- time meas-
urement implementation for quality improvement purposes. We found 
further support for Carter’s12 work highlighting the challenge of col-
lecting real- time patient- reported data following a clinical visit, where 
patients often face time constraints that lead them not to complete 
real- time patient experience measures. These constraints highlight 
the difficulty of collecting post- visit surveys in clinic, as compared to 
screening measures commonly collected in clinic waiting rooms prior 
to clinic visits such as the PHQ- 2 for depression. SDM interventions, 
such as decision aids, also face barriers to implementation due in part 
to uncertainty about the effect of decision aid use on length of the 
clinical consultation.22
4.4 | Implications
4.4.1 | Practice implications
This study demonstrates that a clinic’s workflow, especially its patient 
checkout procedure, plays a key role in successful in- clinic implemen-
tation of a patient experience measure. Ensuring staff commitment to 
survey administration is a key issue in maximizing response rates to in- 
clinic patient surveys. Strong clinical leadership and engagement may 
play a role in enhancing staff commitment to survey administration, 
as may financial incentives to staff members required to go above 
and beyond their usual duties. For technological solutions, efficient 
and seamless integration with administrative systems is a key require-
ment. Avoiding the burden of long- term data collection (as in Site 1) in 
favour of sampling for shorter time periods (as in Sites 2 and 3) seems 
to lead to better response rates. Technological survey administration 
also helps boost response rates.
4.4.2 | Policy implications
There is a significant risk that patient experience measurement could 
become a burden to both patients and administrators unless efforts 
are made to make the process efficient, time- limited, and most of 
all, relevant. Existing outpatient surveys, such as the Clinician and 
Group Consumer Assessment of Healthcare Providers & Systems 
(CG- CAHPS),7 measure important elements of patient- centred care 
including satisfaction with communication, facilities and clinic staff. 
However, CG- CAHPS lacks items directly assessing the process of 
SDM and takes the form of a lengthy questionnaire.7 This level of 
measurement cannot be sustained unless there is interest in using the 
data for quality improvement, and it is helpful for the motivation for 
such use to arise from the organization undertaking the measurement. 
Episodic use of short measurement tools could reduce this burden.
We conclude that collecting real- time data about key aspects of 
patient experience is not easy. Ensuring that the data are made avail-
able for clinicians and management so that it can be used for timely 
quality improvement is a research frontier yet to be explored.
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APPENDIX 1  Detailed descriptions of survey administration modes
Mode 1: Paper in- clinic survey After their visits, patients visited a member of the clinic’s administrative staff to receive after- visit summaries and 
to schedule potential follow- up visits. They were given the CollaboRATE survey at this point by the administra-
tive staff person and asked to leave completed surveys in locked survey receptacles.
Mode 2: Patient portal online 
survey
We delivered CollaboRATE using an online patient portal (MyChart) survey, part of the clinic’s electronic medical 
record. Programming was performed by the medical centre’s information systems department. As clinical 
encounters were completed, emails containing a web link to the CollaboRATE survey were automatically sent to 
patients who had portal accounts.
Mode 3: Interactive voice 
response (IVR)
CollaboRATE was delivered to patients by telephone using an interactive voice response system, programmed by 
the medical centre’s information systems department. An automated telephone call was made to each patient’s 
cell phone number at 7:00 pm on the day of their clinic visit. Before initiating the survey, the respondent was 
asked to confirm that he or she was the individual who had visited the clinic that day. Upon confirmation, 
numerical keypad responses to CollaboRATE questions were requested. If any of the three CollaboRATE 
questions remained incomplete at 7:00 pm the following day, an identical automatic call was placed at that time.
Mode 4: Short message service 
(SMS text messages)
Text messages were sent to patient cell phones at 7:00 pm on the day of their clinical visits, programmed by the 
medical centre’s information systems department. The first message introduced the survey and offered an opt 
out opportunity. Remaining messages each contained a single CollaboRATE question and response instructions. 
Subsequent messages were triggered by each further reply. If any of the three CollaboRATE questions remained 
incomplete at 7:00 pm the following day, the first introductory text message was re- sent.
Mode 5: Tablet and mail Using tablet computers, research assistants offered patients an opportunity to complete an online version of 
CollaboRATE as they left the clinic, hosted in Qualtrics (Qualtrics LLC, Provo, UT). Patients who declined the 
tablet opportunity were asked to complete and return a paper- based survey by mail in a postage- paid envelope.
APPENDIX 2  Characteristics contributing to variation in CollaboRATE scores: mixed- effects logistic regression with interactions by site
Random effects Variance estimate 95% Confidence interval
Clinician 0.143 0.074 0.276
Fixed effectsa Odds ratio 95% Confidence interval
Site 1: Lebanon, NH (reference) 1.000 – –
Site 2: Los Gatos, CA 0.928 0.365 2.360
Site 3: Chelsea, MA 1.576 0.789 3.151
Patient age 1.018 1.014 1.022
Female patient gender 1.181 1.020 1.367
Constant 1.476 1.042 2.090
Interactions Odds ratio 95% Confidence interval Χ2b Pb
Female patient gender by Site 2.41 .299
Female patient gender x Site 2 1.567 0.880 2.789
Female patient gender x Site 3 1.093 0.737 1.621
Patient age by Site 0.48 .785
Patient age x Site 2 0.995 0.979 1.011
Patient age x Site 3 1.001 0.990 1.012
aOdds ratios for survey administration modes are available upon request.
 btwo degree- of- freedom tests of whether there was a difference from odds ratio of 1 for the two interaction contrasts whose effects are identi-
fied (Sites 2 and 3) against the baseline interaction contrast (of Site 1).
